Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRolls-Royce Regulatory News (RR.)

Share Price Information for Rolls-Royce (RR.)

Share Price is delayed by 15 minutes
Get Live Data
1,388.20    -23.60 (-1.67%)
Bid:
1,387.80
Ask:
1,388.20
Spread: 0.40 (0.029%)
Market Cap: £115.05b
RR. Live PriceLast checked at - London Stock Exchange

Intraday Rolls-Royce Share Chart

Statement re: Media Speculation

21 Sep 2020 08:26

RNS Number : 5022Z
Rolls-Royce Holdings plc
21 September 2020
 

21 September 2020

STATEMENT RE: MEDIA SPECULATION

 

Rolls-Royce notes the continued media speculation regarding the possibility of the Group undertaking a fund raising.

 

We continue to review all funding options to enhance balance sheet resilience and strength. Amongst other options, we are evaluating the merits of raising equity of up to £2.5bn, through a variety of structures including a rights issue and potentially other forms of equity issuance. Our review also includes new debt issuance.

 

No final decisions have been taken as to whether or when to proceed with any of these options or as to the precise amount that may be raised.

 

As we said on 27 August 2020, following rapid management actions to reduce costs and secure additional liquidity, we started the second half of 2020 with liquidity of £6.1bn (comprising £4.2bn cash at end June and a £1.9bn undrawn revolving credit facility). In addition, we finalised a £2bn undrawn term loan, partly backed by the UK Export Finance, in August. We have also launched a major restructuring of our Group, in particular our Civil Aerospace business, with forecast annualised pre-tax savings of over £1.3bn by the end of 2022. As previously announced, we have also already identified a number of potential disposals that are expected to generate proceeds of more than £2bn over the next 18 months, including ITP Aero.

 

A further announcement will be made if and when appropriate.

 

This announcement has been determined to contain inside information.

 

About Rolls-Royce Holdings plc

 

1. Rolls-Royce pioneers cutting-edge technologies that deliver clean, safe and competitive solutions to meet our planet's vital power needs.

 

2. Rolls-Royce has customers in more than 150 countries, comprising more than 400 airlines and leasing customers, 160 armed forces, 70 navies, and more than 5,000 power and nuclear customers.

 

3. Annual underlying revenue was £15.45 billion in 2019, around half of which came from the provision of aftermarket services.

 

4. In 2019, Rolls-Royce invested £1.46 billion on research and development. We also support a global network of 29 University Technology Centres, which position Rolls-Royce engineers at the forefront of scientific research.

 

5. Rolls-Royce Holdings plc LEI: 213800EC7997ZBLZJH69

 

 

 

For further information, please contact:

 Media

Richard Wray

Director of External Communications & Brand, Rolls-Royce plc

Tel +44 (0) 7810 850055

Richard.Wray@Rolls-Royce.com

 Investors

Isabel Green

Head of Investor Relations, Rolls-Royce plc

Tel +44 (0) 7880 160976

Isabel.Green@Rolls-Royce.com

 

www.Rolls-Royce.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
SPCUKABRRSUKAAR
Date   Source Headline
2nd Aug 20237:00 amRNSDirectorate Change
31st Jul 20239:30 amRNSDirector/PDMR Shareholding
26th Jul 20237:00 amRNSTrading Update
20th Jul 20239:00 amRNSDirectorate Change
10th Jul 20233:30 pmRNSDirector/PDMR Shareholding
3rd Jul 20239:32 amRNSTotal Voting Rights
28th Jun 20233:30 pmRNSDirector/PDMR Shareholding
27th Jun 202312:00 pmRNSAdmission of Shares
8th Jun 20232:00 pmRNSDirector/PDMR Shareholding
30th May 202312:00 pmRNSDirector/PDMR Shareholding
19th May 202312:00 pmRNSDirector/PDMR Shareholding
11th May 20232:07 pmRNSResult of AGM
11th May 20239:14 amRNSDirector/PDMR Shareholding
11th May 20237:00 amRNSAGM Statement and Trading Update
10th May 20234:00 pmRNSDirectorate change & withdrawal of AGM resolution
28th Apr 20233:44 pmRNSDirector/PDMR Shareholding
14th Apr 20239:30 amRNSDirector/PDMR Shareholding
11th Apr 20231:00 pmRNSHolding(s) in Company
31st Mar 20237:00 amRNSDirectorate Change
29th Mar 20239:34 amRNSDirector/PDMR Shareholding
21st Mar 20233:03 pmRNSDirector/PDMR Shareholding
17th Mar 20233:00 pmRNSDirector/PDMR Shareholding
10th Mar 20232:35 pmRNSDirector/PDMR Shareholding
8th Mar 20233:39 pmRNSDirector/PDMR Shareholding
2nd Mar 20239:00 amRNSAnnual Report 2022 and Annual General Meeting 2023
1st Mar 20235:05 pmRNSHolding(s) in Company
28th Feb 20234:17 pmRNSDirector/PDMR Shareholding
24th Feb 202312:00 pmRNSDirector/PDMR Shareholding
23rd Feb 20237:00 amRNS2022 Full Year Results
10th Feb 20239:09 amRNSDirector Declaration
9th Feb 20239:30 amRNSDirector/PDMR Shareholding
9th Feb 20237:00 amRNSDirectorate Change
31st Jan 20239:30 amRNSDirector/PDMR Shareholding
11th Jan 20233:50 pmRNSDirector/PDMR Shareholding
22nd Dec 202211:05 amRNSDirector/PDMR Shareholding
21st Dec 20229:37 amRNSDirectorate Change
8th Dec 20222:37 pmRNSDirector/PDMR Shareholding
5th Dec 20224:04 pmRNSDirector/PDMR Shareholding
29th Nov 20229:30 amRNSDirector/PDMR Shareholding
18th Nov 202210:07 amRNSHolding(s) in Company
14th Nov 202210:00 amRNSHolding(s) in Company
10th Nov 20229:15 amRNSHolding(s) in Company
9th Nov 20222:40 pmRNSDirector/PDMR Shareholding
3rd Nov 20227:00 amRNSTrading Statement
31st Oct 20229:30 amRNSDirector/PDMR Shareholding
18th Oct 20222:45 pmRNSDirector Declaration
13th Oct 20223:15 pmRNSHolding(s) in Company
10th Oct 20225:11 pmRNSDirector/PDMR Shareholding
10th Oct 20229:30 amRNSHolding(s) in Company
5th Oct 20225:05 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.